Perinatal Outcomes in Type 2 Diabetes

被引:0
|
作者
Niranjala M. Hewapathirana
Helen R. Murphy
机构
[1] Nottingham University Hospitals NHS Trust,MRCP, Queens Medical Centre
[2] University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Center,Level 4 Metabolic Research Laboratories
[3] Institute of Metabolic Science,undefined
来源
Current Diabetes Reports | 2014年 / 14卷
关键词
Congenital malformation (CM); Large for gestational age (LGA); Macrosomia; Perinatal mortality (PNM); Stillbirth (SB); Neonatal mortality (NM); Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Over the past decade the prevalence of type 2 diabetes in pregnancy has continued to increase. It is vital that health care professionals recognize that preconception care is just as important for mothers with type 2 diabetes as it is in type 1 diabetes. All women with type 2 diabetes should be advised regarding safe effective contraception and the benefits of optimal glycemic control, folic acid supplementation, and avoidance of potentially harmful mediations before attempting pregnancy. Glycemic control is the most important modifiable risk factor for congenital anomaly in women with type 2 diabetes, whereas maternal obesity and social disadvantage are associated with large for gestational age neonates. This review aims to bring the reader up to date with the burden of perinatal outcomes and clinical interventions to improve maternal and infant health. It warns that the consequences of type 2 diabetes pregnancy do not end at birth.
引用
收藏
相关论文
共 50 条
  • [31] Insulin treatment, insulin requirements and perinatal outcomes in a pregnancy cohort with type 1 diabetes
    Pilar Bahillo-Curieses, M.
    Matias del Pozo, Vanesa
    Alvarez Colomo, Cristina
    Diaz-Soto, Gonzalo
    ANALES DE PEDIATRIA, 2021, 94 (02): : 107 - 109
  • [32] Risk of Adverse Perinatal Outcomes in Hispanic Women With Pregestational Type 1 Diabetes Mellitus
    Banegas Echeverria, Milady
    Arce, Lidia
    Flores Robles, Claudia
    Martinez Cruz, Nayeli
    Reyes Munoz, Enrique
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 34S - 34S
  • [33] Method of insulin delivery does not affect perinatal outcomes with type 1 diabetes mellitus
    Sobhani, Nasim C.
    Watson, Katarina
    Kannan, Akshaya
    Patzek, Sophie
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (10)
  • [34] Perinatal outcomes and time-in-range on continuous glucose monitoring for type 1 diabetes
    Sobhani, Nasim C.
    Goemans, Sophie L.
    Nguyen, Antoinette
    Richley, Michael
    Gabby, Lauryn
    Han, Christina S.
    Ramos, Gladys A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S72 - S73
  • [35] Diabetes Technology in Pregnant Women with Type 1 Diabetes-Distribution and Effects on Glycemic Regulation and Perinatal Outcomes
    Ghaur, Sara Yalda
    Grinderslev, Pernille Bundgaard
    Leth-Moller, Magnus
    Ovesen, Per Glud
    Fuglsang, Jens
    Fisker, Sanne
    McIntyre, H. David
    Kampmann, Ulla
    REPRODUCTIVE MEDICINE, 2024, 5 (01): : 12 - 22
  • [36] Microvascular outcomes in type 2 diabetes Reply
    Zoungas, Sophia
    Gerstein, Hertzel C.
    Holman, Rury R.
    Reaven, Peter
    Woodward, Mark
    Arima, Hisatomi
    Coleman, Ruth L.
    Chalmers, John
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : 580 - 580
  • [37] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Singh, Sonal
    Furberg, Curt D.
    HEART, 2009, 95 (01) : 1 - 3
  • [38] Liraglutide and Renal Outcomes in Type 2 Diabetes
    Mann, Johannes F. E.
    Orsted, David D.
    Brown-Frandsen, Kirstine
    Marso, Steven P.
    Poulter, Neil R.
    Rasmussen, Soren
    Tornoe, Karen
    Zinman, Bernard
    Buse, John B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 839 - 848
  • [39] Canagliflozin and cardiovascular outcomes in Type 2 diabetes
    Sarraju, Ashish
    Spencer-Bonilla, Gabriela
    Rodriguez, Fatima
    Mahaffey, Kenneth W.
    FUTURE CARDIOLOGY, 2020, 17 (01) : 39 - 48
  • [40] Empagliflozin and cardiovascular outcomes in type 2 diabetes
    Gregory B. Lim
    Nature Reviews Cardiology, 2016, 13 (1) : 3 - 3